July 3 (Reuters) - Beam Therapeutics Inc BEAM.O:
BEAM THERAPEUTICS INC - BUYS EARLY-STAGE LIFE SCIENCES COMPANY - SEC FILING
BEAM THERAPEUTICS INC - POTENTIAL ADDITIONAL PAYMENTS UP TO $89 MILLION - SEC FILING
BEAM THERAPEUTICS INC - MAXIMUM OF 5.2 MILLION MILESTONE SHARES ISSUABLE AT $17.01 PER SHARE - SEC FILING
Further company coverage: BEAM.O
((Reuters.Briefs@thomsonreuters.com;))
精彩评论